核苷中间体在药物合成中扮演着重要角色,特别是在抗病毒和抗癌药物的开发中。这些化合物通常用于合成最终的活性物质。核苷是一类含糖结构的重要生物分子,在体内参与DNA和RNA的构成与代谢。
核苷中间体是指从基本原料出发,通过一系列化学反应合成得到的、接近或直接作为后续步骤前驱体的化合物。它们在药物研发过程中至关重要,因为这些中间体可以提供更便捷的方法来引入特定官能团或结构片段,从而简化整个合成路线,提高产率并减少副产品的生成。
核苷中间体的合成通常包括以下几个关键步骤:
这些中间体在合成过程中具有高度选择性和反应性,在特定条件下能够精确地进行化学转化。因此,它们对于确保目标产品的高质量生产和高效开发至关重要。此外,不同类型的核苷中间体可以用于制备不同的药物分子,如抗病毒药物(例如阿昔洛韦)、抗癌药物以及其他多种生物活性物质。
中文名称 | 英文名称 | CAS号 | 化学式 | 结构式图片 |
---|---|---|---|---|
鸟嘌呤核糖苷-3’,5’-环磷酸酯 | cyclic guanosine 3',5'-monophosphate | 7665-99-8 | C10H12N5O7P |
|
苯甲酰胞苷 | N4-benzoylcytidine | 13089-48-0 | C16H17N3O6 |
|
腺苷酸2(3)-磷酸 | adenosine 2'-monophosphate | 130-49-4 | C10H14N5O7P |
|
腺苷-5′-三磷酸二钠盐(ATP) | Adenosine 5'-Triphosphate, disodium salt | 987-65-5 | C10H16N5O13P3.2Na |
|
腺苷-5'-二磷酸三锂盐 | Adenosine 5'-(trihydrogen diphosphate), trilithium salt | 31008-64-7 | C10H12Li3N5O10P2 |
|
腺嘌呤盐酸盐 | adenine hydrochloride | 2922-28-3 | C5H5N5*ClH |
|
胞苷-5’-三磷酸二钠盐 | CTP xsodium | 18423-42-2 | C9H15N3O14P3*Na |
|
胞啶3'-单磷酸 | cytidine 3'-monophosphate | 84-52-6 | C9H14N3O8P |
|
玉米素核苷 | trans-zeatin 9-β-D-ribofuranoside | 6025-53-2 | C15H21N5O5 |
|
激动素核苷 | kinetin riboside | 4338-47-0 | C15H17N5O5 |
|
洛索立宾 | loxoribine | 121288-39-9 | C13H17N5O6 |
|
氯鳥嘌呤 | 8-Chloroguanin | 22052-03-5 | C5H4ClN5O |
|
杀结核菌素 | tubercidin | 69-33-0 | C11H14N4O4 |
|
尿苷5-单磷酸 | 5'-Uridylic Acid | 58-97-9 | C9H13N2O9P |
|
利波腺苷 | 6-N-(2-isopentenyl)adenosine | 7724-76-7 | C15H21N5O4 |
|
二丁酰环磷腺苷 | dibutyryl cyclic AMP | 362-74-3 | C18H24N5O8P |
|
N6-苯甲酰基腺苷 | N-benzoyladenosine | 4546-55-8 | C17H17N5O5 |
|
N6,N6-二甲基腺苷 | N,N-dimethyladenosine | 2620-62-4 | C12H17N5O4 |
|
N4-苯甲酰-2'-甲氧基胞苷 | 2'-O-methyl-N<sup>4</sup>-benzoylcytidine | 52571-45-6 | C17H19N3O6 |
|
N4-氨基胞苷 | N<sup>4</sup>-aminocytidine | 57294-74-3 | C9H14N4O5 |
|
N2-苯甲酰基-D-鸟苷 | N<sup>2</sup>-benzoylguanosine | 3676-72-0 | C17H17N5O6 |
|
N2-异丁酰基鸟苷一水合物 | N<sup>2</sup>-isobutyryl-2'-deoxyguanosine | 64350-24-9 | C14H19N5O6 |
|
N2,N2-二甲基鸟苷 | N2,N2-dimethylguanosine | 2140-67-2 | C12H17N5O5 |
|
N-乙酰胞嘧啶核苷 | N-acetylcytidine | 3768-18-1 | C11H15N3O6 |
|
N-2-乙酰鸟嘌呤 | N-(6-oxo-6,9-dihydro-1H-purin-2-yl)acetamide | 19962-37-9 | C7H7N5O2 |
|
N-(9-((2r,3r,4r,5r)-5-((双(4-甲氧基苯基)(苯基)甲氧基)甲基)-4-羟基-3-甲氧基四氢呋喃-2-基)-9h-嘌呤-6-基)苯甲酰胺 | N<sup>6</sup>-benzoyl-5'-(4,4'-dimethoxytrityl)-O<sup>2'</sup>-methyladenosine | 110764-72-2 | C39H37N5O7 |
|
N,9-二乙酰鸟嘌呤 | 2,9-diacetylguanine | 3056-33-5 | C9H9N5O3 |
|
9-甲基腺嘌呤 | 3-methyladenine | 700-00-5 | C6H7N5 |
|
9-(4-乙酰氧基-3-乙酰氧甲基丁基)-2-氨基-6-氯嘌呤 | 9-(4-acetoxy-3-acetoxymethylbutyl)-2-amino-6-chloropurine | 97845-60-8 | C14H18ClN5O4 |
|
8-羟基鸟苷 | 8-Hydroxyguanosine | 3868-31-3 | C10H13N5O6 |
|
8-硝基鸟嘌呤 | 8-nitroguanine | 168701-80-2 | C5H4N6O3 |
|
8-溴黄嘌呤 | 8-bromo-3,7(9)-dihydro-purine-2,6-dione | 10357-68-3 | C5H3BrN4O2 |
|
8-溴鸟嘌呤 | 8-bromoguanine | 3066-84-0 | C5H4BrN5O |
|
8-溴膘苷 | 8-bromoadenosine | 2946-39-6 | C10H12BrN5O4 |
|
8-溴腺苷3′,5′-环单磷酸 | Br-cAMP | 23583-48-4 | C10H11BrN5O6P |
|
8-溴腺苷-3,5-环单磷酸钠 | 8-bromoadenosine 3',5'-cyclic monophosphate sodium salt | 76939-46-3 | C10H10BrN5O6P*Na |
|
8-溴腺嘌呤 | 8-bromoadenine | 6974-78-3 | C5H4BrN5 |
|
8-溴肌苷 | 8-bromoinosine | 55627-73-1 | C10H11BrN4O5 |
|
8-氯腺嘌呤核苷 | 8-chloroadenosine | 34408-14-5 | C10H12ClN5O4 |
|
8-氨基腺苷酸 | 8-aminoadenosine | 3868-33-5 | C10H14N6O4 |
|
8-叠氮酰苷-5’-三磷酸钠 | 8-Azido-ATP | 53696-59-6 | C10H15N8O13P3 |
|
7-甲基鸟苷 | 7-methylguanosine | 20244-86-4 | C11H16N5O5 |
|
7-甲基鸟苷 | 7-methyl-guanosine | 15313-37-8 | C11H17N5O5 |
|
6H-嘌呤-6-硫酮,1,9-二氢-9-b-L-呋喃核糖基- | 9β-ribofuranosyl-purin-6-thione | 7687-43-6 | C10H12N4O4S |
|
6-苄基腺苷 | N6-Benzyladenosine | 4294-16-0 | C17H19N5O4 |
|
6-疏基嘌呤核苷 | 6-mercaptopurine riboside | 574-25-4 | C10H12N4O4S |
|
6-甲硫基嘌呤核苷 | 6-Methylmercaptopurine riboside | 342-69-8 | C11H14N4O4S |
|
6-氯鸟嘌呤核苷 | 2-Amino-6-chloropurine riboside | 2004-07-1 | C10H12ClN5O4 |
|
6-氯嘌呤核苷 | 6-Chloropurine riboside | 5399-87-1 | C10H11ClN4O4 |
|
6-氯-9-beta-D-呋喃木糖基-9H-嘌呤-2-胺 | 2-amino-6-chloropurine riboside | 2004-07-1 | C10H12ClN5O4 |
|